Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Míreanna comhchosúla

• Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.
  de réir: Miller, P, et al.
  Foilsithe / Cruthaithe: (2005)
• Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis.
  de réir: Cooper, C, et al.
  Foilsithe / Cruthaithe: (2003)
• A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.
  de réir: Reginster, J, et al.
  Foilsithe / Cruthaithe: (2006)
• Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation.
  de réir: Delmas, P, et al.
  Foilsithe / Cruthaithe: (2005)
• Prospective clinical study of once monthly ibandronate in the treatment of osteoporosis and prevention of fractures in postmenopausal women: Orpheum study
  de réir: Bumbaširević Marko, et al.
  Foilsithe / Cruthaithe: (2011-01-01)